Area of research
Infectious Diseases · Immunology
Research interest
Research interests include COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Immune responses and vaccinations, and Long-Term Effects of COVID-19.
A multiomics recovery factor predicts long COVID in the IMPACC study
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors
High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19
MICBG406A polymorphism reduces risk of mechanical ventilation and death during viral acute lung injury
Identification of a multi-omics factor predictive of long COVID in the IMPACC study
Minimalistic Transcriptomic Signatures Permit Accurate Early Prediction of COVID-19 Mortality
Baseline predictors for 28-day COVID-19 severity and mortality among hospitalized patients: results from the IMPACC study
Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC study.
Minimalistic transcriptomic signatures permit accurate early prediction of COVID-19 mortality
Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology
Chronic Viral Reactivation and Associated Host Immune Response and Clinical Outcomes in Acute COVID-19 and Post-Acute Sequelae of COVID-19
Breastfeeding and Neonatal Age Influence Neutrophil‐Driven Ontogeny of Blood Cell Populations in the First Week of Human Life
Unraveling SARS-CoV-2 Host-Response Heterogeneity through Longitudinal Molecular Subtyping
Plasma adenosine deaminase-1 and -2 activities are lower at birth in Papua New Guinea than in The Gambia but converge over the first weeks of life
Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients
Integrated longitudinal multi-omics study identifies immune programs associated with COVID-19 severity and mortality in 1152 hospitalized participants
Corrigendum to “Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study” [eBioMedicine 83 (2022) 104208]
Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses
Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study
The Immune Signatures data resource, a compendium of systems vaccinology datasets
Bacille Calmette-Guérin vaccine reprograms human neonatal lipid metabolism in vivo and in vitro
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study
A single birth dose of Hepatitis B vaccine induces polyfunctional CD4+ T helper cells
BCG vaccination–induced emergency granulopoiesis provides rapid protection from neonatal sepsis
Licensed Bacille Calmette-Guérin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation
Preparing for Life: Plasma Proteome Changes and Immune System Development During the First Week of Human Life
Towards Precision Vaccines: Lessons From the Second International Precision Vaccines Conference
Clinical Protocol for a Longitudinal Cohort Study Employing Systems Biology to Identify Markers of Vaccine Immunogenicity in Newborn Infants in The Gambia and Papua New Guinea